Welcome to Cato Research

Cato Research is a full-service contract research and development organization with international resources dedicated to helping pharmaceutical and biotechnology companies efficiently and expeditiously navigate the regulatory approval process in order to bring new drugs, biologics, and medical devices to the people who need them.

» Cato Research Overview | Contact Us

Announcements

  • Cato Research was named the #2 Healthiest Employer by the Triangle Business Journal.

  • Cato Research Canada is celebrating their 20th anniversary in 2012!

  • Cato BioVentures, the venture capital affiliate of Cato Research, has launched a new website! Visit Cato BioVentures to learn about our investment model.

  • Cato Research is a proud member of the BIOCOM CRO Initiative!

    BIOCOM member

Recent Posts

  • November 29, 2011 - Fifth China Medicinal Biotech Forum – Conference Recap – I recently returned from the Fifth China Medicinal Biotech Forum held in Beijing, China from 07-09 November 2011. The purpose of this conference was to update graduate students in China on the latest trends in biotechnology. [...]

  • November 2, 2011 - Project Management for Biotech Companies – In today's fast paced, high pressure world of drug development there are multiple factors that can and do affect marketing success. Large organizations understand the value that project management can contribute to a successful project. [...]

  • October 25, 2011 - Pre-IND Submissions in eCTD Format – Historically, we made our Pre-IND submissions in paper (e.g., Pre-IND meeting request, briefing package, and meeting minutes) and we began using eCTD format with the initial IND submission. [...]

  • More Posts...